Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trial
Fig 1
Patient flow.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Patient flow.